RIVAROXABAN

Product NDC
31722-496
11-digit product format
317220496
Labeler code
31722
Product ID
31722-496_d1afd534-ca74-462d-9cbb-03e54547cd9a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
RIVAROXABAN
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Camber Pharmaceuticals, Inc.
Application
ANDA219332
Marketing category
ANDA
Marketing start
2025-05-20
Substance
RIVAROXABAN
Active strength
2.5 mg/1
Pharmacologic classes
Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219332-001RIVAROXABANRIVAROXABAN2.5MGTABLET / ORALAB2025-05-14
A219332-002RIVAROXABANRIVAROXABAN10MGTABLET / ORALAB2025-05-14
A219332-003RIVAROXABANRIVAROXABAN15MGTABLET / ORALAB2025-05-14
A219332-004RIVAROXABANRIVAROXABAN20MGTABLET / ORALAB2025-05-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A219332-001AB
A219332-002AB
A219332-003AB
A219332-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A219332-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-1484e616aacf4f…
2026-09-14 22:38:342026-08A219332-002RIVAROXABAN10MGTABLET / ORALAB2025-05-1484e616aacf4f…
2026-09-14 22:38:342026-08A219332-003RIVAROXABAN15MGTABLET / ORALAB2025-05-1484e616aacf4f…
2026-09-14 22:38:342026-08A219332-004RIVAROXABAN20MGTABLET / ORALAB2025-05-1484e616aacf4f…
2026-08-18 06:07:402026-07A219332-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-08-18 06:07:402026-07A219332-002RIVAROXABAN10MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-08-18 06:07:402026-07A219332-003RIVAROXABAN15MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-08-18 06:07:402026-07A219332-004RIVAROXABAN20MGTABLET / ORALAB2025-05-14caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A219332-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219332-002RIVAROXABAN10MGTABLET / ORALAB2025-05-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219332-003RIVAROXABAN15MGTABLET / ORALAB2025-05-14011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219332-004RIVAROXABAN20MGTABLET / ORALAB2025-05-14011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219332-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219332-002RIVAROXABAN10MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219332-003RIVAROXABAN15MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219332-004RIVAROXABAN20MGTABLET / ORALAB2025-05-1431067a03dcf5…
2025-08-23 18:47 UTC2025-08A219332-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A219332-002RIVAROXABAN10MGTABLET / ORALAB2025-05-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A219332-003RIVAROXABAN15MGTABLET / ORALAB2025-05-146a471c1ec25d…
2025-08-23 18:47 UTC2025-08A219332-004RIVAROXABAN20MGTABLET / ORALAB2025-05-146a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219332-001RIVAROXABAN2.5MGTABLET / ORALAB2025-05-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219332-002RIVAROXABAN10MGTABLET / ORALAB2025-05-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219332-003RIVAROXABAN15MGTABLET / ORALAB2025-05-14a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219332-004RIVAROXABAN20MGTABLET / ORALAB2025-05-14a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A219332-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A219332-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A219332-003AB184e616aacf4f…
2026-09-14 22:38:342026-08A219332-004AB184e616aacf4f…
2026-08-18 06:07:402026-07A219332-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A219332-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A219332-003AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A219332-004AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A219332-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219332-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219332-003AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219332-004AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219332-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219332-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219332-003AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219332-004AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A219332-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A219332-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A219332-003AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A219332-004AB16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219332-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219332-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219332-003AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219332-004AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
RIVAROXABAN
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
RIVAROXABAN2.5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9NDF7JZ4M3Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2059015Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
45f16f1b-e405-4aa6-bc8b-977d4864af3eAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6cd5c957-f63d-4ae5-a5e5-4e6830870998Product name320251209

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
31722-496-18RIVAROXABAN180 in 1 BOTTLETABLET, FILM COATED1801
31722-496-60RIVAROXABAN60 in 1 BOTTLETABLET, FILM COATED601

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
31722-496-18EA - Each31722-496c39e1e3e-9b4c-48be-9fa5-67b0979f4d7512025-06-13
31722-496-60EA - Each31722-4963b804b75-85a4-457c-8d92-7aa376aac91f12025-06-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
31722-496RIVAROXABAN TABLET, FILM COATED [CAMBER PHARMACEUTICALS, INC.]1Current NDC, 2 package rows20250521_45f16f1b-e405-4aa6-bc8b-977d4864af3e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RIVAROXABANRIVAROXABANXLCare Pharmaceuticals, Inc.291011aa-60eb-4109-b59c-1c521fbeac4f2025-06-17Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219332
application number: ANDA219332
RIVAROXABANRIVAROXABANCamber Pharmaceuticals, Inc.45f16f1b-e405-4aa6-bc8b-977d4864af3e2025-05-17Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219332
application number: ANDA219332
ndc (product): 31722-496

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2059015rivaroxaban 2.5 MG Oral TabletPSN45f16f1b-e405-4aa6-bc8b-977d4864af3e1
2059015rivaroxaban 2.5 MG Oral TabletSCD45f16f1b-e405-4aa6-bc8b-977d4864af3e1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
31722-496-1831722049618180 TABLET, FILM COATED in 1 BOTTLE (31722-496-18) 2025-05-20NoNoCurrent
31722-496-603172204966060 TABLET, FILM COATED in 1 BOTTLE (31722-496-60) 2025-05-20NoNoCurrent